List of Medidata Clinical Data Studio Customers
Velizy-Villacoublay, 78140,
France
Since 2010, our global team of researchers has been studying Medidata Clinical Data Studio customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Medidata Clinical Data Studio for Clinical Trial Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Medidata Clinical Data Studio for Clinical Trial Management include: ICON, a Ireland based Healthcare organisation with 41150 employees and revenues of $8.12 billion, Eisai, a Japan based Life Sciences organisation with 11076 employees and revenues of $4.92 billion, Eisai United States, a United States based Life Sciences organisation with 3000 employees and revenues of $1.60 billion, Corcept Therapeutics, a United States based Life Sciences organisation with 238 employees and revenues of $366.0 million, Bioforum the Data Masters, a Israel based Professional Services organisation with 200 employees and revenues of $30.0 million and many others.
Contact us if you need a completed and verified list of companies using Medidata Clinical Data Studio, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Medidata Clinical Data Studio customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Bioforum the Data Masters | Professional Services | 200 | $30M | Israel | Dassault Systemes | Medidata Clinical Data Studio | Clinical Trial Management | 2024 | n/a |
In 2024 Bioforum the Data Masters expanded its longstanding partnership with Medidata by adding Medidata Clinical Data Studio to its biometric and data management services, an addition announced under an enterprise agreement. The announcement explicitly cites Clinical Data Studio alongside Medidata Rave EDC and Rave RTSM to support Bioforum's global clinical data and RBQM offerings, positioning this work within the Clinical Trial Management category.
The implementation of Medidata Clinical Data Studio is focused on centralizing data ingest and harmonization for sponsor studies, enabling automated data quality checks and standardized curation workflows that support downstream biometrics. Medidata Clinical Data Studio is configured to supplement Bioforum’s existing biometric pipelines, providing capabilities for consolidated data views, event driven data validation, and tooling that accelerates sponsor analyses without requiring mention of prior platform names.
Integrations in the implementation explicitly include Medidata Rave EDC and Medidata Rave RTSM, enabling bidirectional data flow between electronic case report forms, randomization and trial supply management, and the Clinical Data Studio repository. Operational coverage is described as global, aligning with Bioforum’s biometric and data management service lines, and the rollout is intended to support clinical operations, data management, and biostatistics teams across studies.
Governance and process changes accompany the deployment under the enterprise agreement, with Bioforum aligning data stewardship processes and standard operating procedures to instrument RBQM signals and centralized data oversight. The stated outcomes include streamlined data flow, maintained data integrity, and accelerated sponsor analyses as direct benefits of adding Medidata Clinical Data Studio to Bioforum’s Clinical Trial Management tooling.
|
 |
Corcept Therapeutics | Life Sciences | 238 | $366M | United States | Dassault Systemes | Medidata Clinical Data Studio | Clinical Trial Management | 2024 | n/a |
In 2024, Corcept Therapeutics implemented Medidata Clinical Data Studio. The company deployed Medidata Clinical Data Studio for Clinical Trial Management to provide real time visibility into study data across its clinical development programs in the United States and to support clinical data management and oversight functions.
The implementation emphasized capabilities for anomaly detection, trend tracking, and centralized data review workflows within Medidata Clinical Data Studio, aligning standard data review procedures with clinical data management operations. These functional modules were used to surface inconsistencies, accelerate issue resolution workflows, and manage data queries more consistently during review cycles.
Rollout targeted clinical data management and oversight teams, standardizing review processes and instituting structured issue resolution workflows to tighten governance around database cleanliness. The deployment supports cleaner, more timely databases for Corcept Therapeutics and establishes a unified data environment for ongoing monitoring and quality control in Clinical Trial Management.
|
 |
Eisai | Life Sciences | 11076 | $4.9B | Japan | Dassault Systemes | Medidata Clinical Data Studio | Clinical Trial Management | 2024 | n/a |
In 2024, Eisai Inc. deployed Medidata Clinical Data Studio as part of its Clinical Trial Management capability. Eisai will leverage Medidata Clinical Data Studio to centralize clinical and patient data, enable execution of scalable and complex clinical trials, and enhance patient experience while maintaining quality and integrity across data sources.
Medidata Clinical Data Studio is powered by the Medidata Platform, providing a unified data management layer that centrally manages disparate data sources and analytics workflows. Implemented functional capabilities include AI driven data review and visualization, concurrent review of patient records, automated import and validation processes, and configuration of data transfer agreements to enforce validation rules and data quality standards.
The deployment integrates Medidata sources including Medidata Rave EDC and non Medidata sources such as laboratory feeds and alternate electronic data capture systems, streamlining imports and standardizing validation across systems. Operational coverage is focused on Eisai Inc. clinical operations and study teams responsible for trial execution, data monitoring, and patient data review.
Governance and workflow adjustments center on configurable data transfer agreements and automated validation to break down data silos and enable tighter data stewardship without adding headcount. The AI driven review capability offers up to 80 percent faster data review while providing a comprehensive, actionable view of patient data, supporting faster identification of data issues and improved collaboration across study teams.
|
 |
|
Life Sciences | 3000 | $1.6B | United States | Dassault Systemes | Medidata Clinical Data Studio | Clinical Trial Management | 2024 | n/a |
|
|
|
|
Healthcare | 41150 | $8.1B | Ireland | Dassault Systemes | Medidata Clinical Data Studio | Clinical Trial Management | 2025 | n/a |
|
Buyer Intent: Companies Evaluating Medidata Clinical Data Studio
- Tandym Group, a United States based Professional Services organization with 300 Employees
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||